Skip to main content
. 2023 Feb 2;5(1):fcad021. doi: 10.1093/braincomms/fcad021

Table 1.

Baseline characteristics of participants

CU n = 44 iRBD n = 22 P-value
Age, years 64.9 (7.5) [51.4, 83.0] 65.4 (8.0) [51.7, 83.3] 0.20
Males, no. (%) 34 (77%) 17 (77%) 1.00
APOE, no. (%) 12 (27%) 5 (28%) 0.84
Education, years 15.3 (2.2) [12, 20] 16.3 (2.6) [12, 20] 0.13
MMSE 28.8 (0.7) [27, 30] 28.7 (1.3) [26, 30] 0.73
CDR-SOB 0.0 (0.1) [0.0, 0.5] 0.2 (0.4) [0.0, 1.0] 0.091
Follow-up, years 3.2 (2.4) [0.0, 7.7] 3.4 (2.6) [0.0, 7.1] 0.29
DaTQuant Putamen NA 1.82 (0.42) [0.56, 2.52]
DaTQuant Caudate NA 2.18 (0.44) [0.77, 2.73]
Parkinsonism, no. (%) NA 2 (10%)
Visual Hallucinations, no. (%) NA 1 (5%)
Fluctuations, no. (%) NA 1 (8%)
RBD Duration, years NA 12.7 (12.5) [1, 41]
RBD Onset Age, years NA 52.2 (17.1) [22, 77]

Values correspond to mean (SD) for the continuous variables and count (%) for the categorical variables. P-values for differences between groups come from conditional logistic models that account for the matching.

APOE, apolipoprotein E; CDR-SOB, Clinical Dementia Rating Sum Of Boxes; CU, clinically unimpaired; iRBD, idiopathic Rapid Eyes Movement (REM) sleep Behaviour Disorder; MMSE, Mini-Mental State Examination.